Recombinant poxvirus and streptococcal M protein vaccine

Details Recombinant poxvirus and streptococcal M protein vaccine Recombinant poxvirus and streptococcal M protein vaccine

1994-03-03

1999-11-16

Stucker, Jeffrey

Chemistry: molecular biology and microbiology

Vector, per se

435885, 530324, 530325, 530326, 530327, 530328, 530350, 930 10, 930200, 935 1, 935 11, 935 12, 935 22, 935 32, 536 231, 536 237, C12N 1563

Patent

active

059856548

ABSTRACT:
Viruses of the family poxviridae such as vaccinia or fowlpox viruses are modified to contain a gene which expresses a protein corresponding to the conserved exposed region of the M6 protein. The modified products are useful as vaccines against streptococcal infection.

REFERENCES:
Hruby et al. (Aug., 1988), PNAS, vol. 85, pp. 5714-5717.
Hollingshead et al. (1986), The Journal of Biological Chemistry vol. 261, No. 4, pp. 1677-1686.
Rice et al. (1985), Journal of Virology, vol. 56, No. 1 pp. 227-239.
Taylor et al. (Dec. 1988) Vaccine, vol. 6, pp. 497-503.

Affiliated with

Also associated with

Rating

Recombinant poxvirus and streptococcal M protein vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant poxvirus and streptococcal M protein vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant poxvirus and streptococcal M protein vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1323584